RSS

AveXis

Biochromatography manufacturing company BIA Separations has announced a collaboration with biotech company AveXis to support the manufacturing processes of Novartis’ gene therapy pipeline. Read more

News

Healthcare solutions provider, Novartis, is set to gain further ground in the area of gene therapy through its agreement to acquire AveXis — US-based clinical stage gene therapy company — for $8.7 billion. Read more

News